Navigation Links
Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
Date:7/30/2009

Findings May Potentially Lead to New Approach to Stroke Treatment

BOCA RATON, Fla., July 30 /PRNewswire-USNewswire/ -- When minimally invasive endovascular (through the vessel) therapy made its debut two decades ago, stroke care underwent a major shift as the "window of treatment" for patients suffering a stroke was expanded to eight hours within symptom onset, rather than the standard three-hour window required by the FDA-approved intravenous tPA therapy. Now, a new retrospective, multi-center study shows that endovascular therapy beyond the eight-hour window restored blood flow in the brain in approximately 74 percent of patients suffering ischemic (caused by a clot) stroke. Presented today at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL, the data suggests that this treatment is safe and potentially leads to improved outcomes for a select number of late-presenting patients, including those who awake with stroke symptoms.

According to lead author Raul Nogueira, M.D., Assistant in Neurology and Radiology at Massachusetts General Hospital -- Harvard Medical School, presentation beyond eight hours of symptom onset has traditionally been the single most important factor in excluding patients from stroke treatment. Thus, continued Nogueira, when brain imaging studies revealed that a significant number of late-presenting stroke patients showed evidence of salvageable brain tissue in the area of the stroke, it was an important avenue to pursue. This meant that endovascular therapy (performed by neurointerventional specialists who use drugs or mechanical devices inserted through a catheter or narrow tube that is threaded up through the vessels directly to the problem site to dispel the clot) could potentially be utilized successfully in these patients.

"As we considered the possibilities, it became an exciting proposit
'/>"/>

SOURCE Society of NeuroInterventional Surgery
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
2. Cyberonics Provides Update on Depression Post-Approval Study
3. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
4. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
5. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
6. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
7. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
8. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
9. New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
10. Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
11. Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC ... which develops, licenses, manufactures, distribut...orted its operating results for the first quarter ... excluding royalty income, were $1,683,673 in the ...ported in the previous year first quarter (FY2009)...
(Date:11/20/2009)...Newswire-FirstCall/ -- Medco Health Solutions, Inc...rmation in American healthcare through an advanced...ng higher quality clinical care and fundamentally ... smarter for the benefit of patients and payors al...ments in its strategy enable "Smarter Medicine" to...
(Date:11/20/2009)... Reportlinker.com announces that a...talogue. ,, Pipettes & Pipettors - A Globa...ker.com/p0164373/Pipettes--Pipettors---A-Global-Ma...m_medium=pr&utm_campaign=prnewswire ,, Pi...rt of any research laboratory. Large-scale applica...
Breaking Medicine Technology:Unilens Vision Reports Record First Quarter Earnings and Royalty Income 2Unilens Vision Reports Record First Quarter Earnings and Royalty Income 3Unilens Vision Reports Record First Quarter Earnings and Royalty Income 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Media source impacts ag biotech communication 10439 1Media source impacts ag biotech communication 10439 2Rice opens Cure for Needy on the Web 10435 1Rice opens Cure for Needy on the Web 10435 2Rice opens Cure for Needy on the Web 10435 3Good Food Great Idea 3A Student Led Solution to Hunger Hits 1 000 000 Meal Milestone 59830 1Good Food Great Idea 3A Student Led Solution to Hunger Hits 1 000 000 Meal Milestone 59830 2Good Food Great Idea 3A Student Led Solution to Hunger Hits 1 000 000 Meal Milestone 59830 3
...SEILLE, France, May 4 Ipsogen SA (Alternext,- FR0... specialized in the,development, the manufacturing...r breast cancer and leukemia, today announces the ...o offer JAK2 molecular diagnostic testing in the U... Ipsogen grants ARUP, a national,clinical and anat...
...TON and CARLSBAD, Calif., May 1 Isis Pharmaceutic...sis and collaborators presented data on numerous a...se. The data were presented during the Arterioscl...nnual Conference. The presentations included data...clinical study of mipomersen in which treatment wi...
Other Medicine Technology:Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays 2Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays 3Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays 4Isis and Collaborators Present New Research at the ATVB Annual Conference 2Isis and Collaborators Present New Research at the ATVB Annual Conference 3Isis and Collaborators Present New Research at the ATVB Annual Conference 4Isis and Collaborators Present New Research at the ATVB Annual Conference 5
(Date:11/23/2009)...Y,Mo.,Nov.23/PRNewswire/--ChristineHoehnehasjoined...nedinsurancebrokerage.HoehnewillserveasanAccountEx...acticeinLockton,s Minneapolis office. ,, (Logo:...351LOGO ) ,, "WearethrilledtohaveChristinejoino...nalBenefitServices."Shebroadensourabilitytoassisto...
(Date:11/23/2009)...suggest that adding flaxseed oil to the diet could...l women and women with diabetes, according to a re... of Food Safety, Nutrition and Public Health . , ... Center, in Cairo, Egypt, have studied the effect ...eed oil in the diet might delay the onset of osteo...
(Date:11/23/2009)... Suite Helps Organizations Meet HIPAA Comp...Enrollment and Eligibility, , ...national, a leading provider of high-performance d...nounced today the launch of new products within it...roviders and other healthcare organizations meet i...
(Date:11/23/2009)...have it take longer to get sick, study finds , ...tists report that a genetic variation appears to p... HIV-infected patients. , In fact, those with...lop AIDS and die of complications of the disease. ...s individuals that make a person more or less susc...
(Date:11/23/2009)...OPEKIDSTOSHOOT15MILLIONFREETHROWSIN2010WORLD,SLARG...NS12-CITYU.S.TOUR&TRIPTOAFRICANEXTYEAR ,, ...ESTSHOT" ,, SEATTLE,Nov.23/PRNewswire-USNewswi...V/AIDS,thousandsnationwidewilltakepartin HoopsofHo...heheartofthemovementis15-year-old AustinGutwein fr...
Breaking Medicine News(10 mins):Health News:Lockton Benefit Group Expands International Benefit Team 2Health News:Flaxseed oil and osteoporosis 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4Health News:Genetic Variant Slows AIDS Progression 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 3
...st, creepiest surprise this Halloween may actually... this Saturday at the American Heart Association c...f as many mini-size Halloween candies when they ke...aturday at the American Heart Association conferen...
... 30, 2007 Thresholds limiting bariatric surgeries...t access for poor and underinsured patients, popul...n analysis led by UT Southwestern Medical Center r...ries under Medicare and Medicaid because some stud...
..., Oct. 30 Medarex, Inc.,(Nasdaq: MEDX ) announce...organ Small/Mid Cap Conference in Boston on Monday...ex,s presentation will be webcast live and will,be... About Medarex Medarex is a biopharmaceutical com...
...f., Oct. 30 Anthera Pharmaceuticals,Inc., a priva...i-inflammatory drugs for chronic and acute disease...appointed to Anthera,s Board of Directors. "Don,s...o large scale Phase III clinical trials," said Pau...
...ic Set to Be First in UK to Offer RapidArc(TM) and...ONDON, Oct. 30 The London Clinic is set to,be the...ed RapidArc(TM),treatments as part of a long-term ...irst in the UK to acquire an,advanced Trilogy(R) a...
...lands, October 30 Organon, the human,healthcare b...t has signed,an exclusive, worldwide license agree...t and commercialization of several antithrombotic ...cology. Under the terms of the agreement, Endotis...
Other Medicine News:Health News:Food 'tricks' that combat sneaky, creepy Halloween treats 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 3Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2Health News:Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems 2Health News:Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems 3Health News:Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma 2Health News:Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma 3Health News:Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma 4
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: